WallStreetZenWallStreetZen

NASDAQ: CNTA
Centessa Pharmaceuticals PLC Stock Ownership - Who owns Centessa Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Centessa Pharmaceuticals PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mario Alberto AccardiChief Executive Officer2026-05-01604$39.42
$23.81kSell
Karen M. AndersonChief People Officer2026-03-2641,076$8.01
$329.02kBuy
Gregory M. WeinhoffChief Business Officer2026-03-2623,998$30.00
$719.94kSell
Gregory M. WeinhoffChief Business Officer2026-03-2623,998$3.85
$92.39kBuy
Karen M. AndersonChief People Officer2026-03-2641,076$30.12
$1.24MSell
Karen M. AndersonChief People Officer2026-03-1710,043$28.10
$282.21kSell
Karen M. AndersonChief People Officer2026-03-1710,043$4.01
$40.27kBuy
Karen M. AndersonChief People Officer2026-03-1664,768$28.21
$1.83MSell
Karen M. AndersonChief People Officer2026-03-1664,768$4.01
$259.72kBuy
Karen M. AndersonChief People Officer2026-03-13109,398$4.01
$438.69kBuy

1 of 8

CNTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTA insiders and whales buy or sell their stock.

CNTA Shareholders

What type of owners hold Centessa Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medicxi Ventures Management Jersey Ltd12.90%19,963,157$798.93MInstitution
Avoro Capital Advisors LLC7.39%11,430,455$457.45MInstitution
Index Venture Life Associates VI Ltd6.44%9,961,789$398.67MInstitution
Gap Bermuda Ltd6.26%9,681,818$387.47MInsider
Adage Capital Partners GP LLC5.77%8,925,010$357.18MInstitution
Pentwater Capital Management LP5.28%8,170,000$326.96MInstitution
Fmr LLC4.43%6,852,047$274.22MInstitution
Ecor1 Capital LLC3.88%6,000,000$240.12MInstitution
Perceptive Advisors LLC3.40%5,258,903$210.46MInstitution
Capital World Investors3.12%4,832,548$193.40MInstitution

1 of 3

CNTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTA91.39%8.61%Net SellingNet Selling
LQDA47.56%52.44%Net SellingNet Selling
COGT93.06%6.94%Net SellingNet Selling
MIRM56.48%43.52%Net BuyingNet Buying
PTCT86.91%13.09%Net SellingNet Selling
View Top Biotech Stocks

Centessa Pharmaceuticals Stock Ownership FAQ

Who owns Centessa Pharmaceuticals?

Centessa Pharmaceuticals (NASDAQ: CNTA) is owned by 96.06% institutional shareholders, 9.05% Centessa Pharmaceuticals insiders, and 0.00% retail investors. Gap Bermuda Ltd is the largest individual Centessa Pharmaceuticals shareholder, owning 9.68M shares representing 6.26% of the company. Gap Bermuda Ltd's Centessa Pharmaceuticals shares are currently valued at $387.47M.

If you're new to stock investing, here's how to buy Centessa Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.